FIGURE 12.
Design and SARs of dual-target inhibitors of BET and HDAC based on a pharmacophore fusion strategy (tetrahydroquinoline skeleton, quinolinone skeleton, and N6-benzoyladenine skeleton)
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.